- Home
- CMPS vs WALD Comparison
CMPS vs WALD Comparison
Compare CMPS & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- WALD
- Stock Information
- Founded
- CMPS 2020
- WALD 1988
- Country
- CMPS United Kingdom
- WALD United States
- Employees
- CMPS N/A
- WALD N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- WALD Package Goods/Cosmetics
- Sector
- CMPS Health Care
- WALD Consumer Discretionary
- Exchange
- CMPS Nasdaq
- WALD Nasdaq
- Market Cap
- CMPS 364.9M
- WALD 333.8M
- IPO Year
- CMPS 2020
- WALD 2021
- Fundamental
- Price
- CMPS $4.59
- WALD $2.40
- Analyst Decision
- CMPS Strong Buy
- WALD Strong Buy
- Analyst Count
- CMPS 7
- WALD 5
- Target Price
- CMPS $18.83
- WALD $5.16
- AVG Volume (30 Days)
- CMPS 1.1M
- WALD 165.9K
- Earning Date
- CMPS 07-31-2025
- WALD 05-13-2025
- Dividend Yield
- CMPS N/A
- WALD N/A
- EPS Growth
- CMPS N/A
- WALD N/A
- EPS
- CMPS N/A
- WALD N/A
- Revenue
- CMPS N/A
- WALD $273,868,000.00
- Revenue This Year
- CMPS N/A
- WALD $16.04
- Revenue Next Year
- CMPS N/A
- WALD $15.86
- P/E Ratio
- CMPS N/A
- WALD N/A
- Revenue Growth
- CMPS N/A
- WALD 25.55
- 52 Week Low
- CMPS $2.49
- WALD $1.98
- 52 Week High
- CMPS $8.54
- WALD $4.96
- Technical
- Relative Strength Index (RSI)
- CMPS 64.81
- WALD 44.25
- Support Level
- CMPS $3.86
- WALD $2.10
- Resistance Level
- CMPS $4.52
- WALD $2.75
- Average True Range (ATR)
- CMPS 0.36
- WALD 0.27
- MACD
- CMPS 0.00
- WALD 0.02
- Stochastic Oscillator
- CMPS 65.63
- WALD 40.00
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.